ArticleEndocrine-related cancer2010

Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.

Yvonne Fierz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.